Portfolio company
Brixton Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
6 investors
Sectors
About
This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
SPR Therapeutics
This company develops peripheral nerve stimulation systems to provide non-surgical pain management for adult patients with chronic or acute pain.
Nervonik
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems for patients suffering from chronic neuropathic pain.
Allay Therapeutics
The company develops long-acting localized pain management technology for patients recovering from surgery.
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
